Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal
- 2 February 2024
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 38 (2)
Abstract
The efficacy and safety of early steroid withdrawal (ESW) in Black renal transplant recipients (RTR) remains uncertain, especially when combined with non‐lymphocyte depleting induction. This study compared patient and graft outcomes of older Black and Non‐Black RTR who received basiliximab induction followed by ESW.Included subjects in this single center, retrospective study were first‐time deceased and living donor RTR aged over 65 years who received basiliximab induction therapy and ESW. Black RTR and Non‐Black deceased donor RTR received an oral prednisone taper starting POD3 which was discontinued by POD21 per protocol.Of 139 patients (55 Black and 84 Non‐Black), the Black patient group included a higher percentage of deceased donors and hepatitis C positive donors, and more frequently underwent renal replacement therapy prior to transplant. One Black and zero Non‐Black RTR experienced graft loss within 3 years (p = 1.0). Patient survival was similar at 1 year (93% vs. 97%, p = .16) and 3 years (91% vs. 96%, p = .17). Rejection‐free survival and biopsy‐proven rejection did not differ at 1 or 3 years. Median eGFR and change in eGFR also did not differ between groups. Black patients were maintained on significantly higher median mycophenolate doses from 6 months post‐transplant to the end of the study period (p = .03 and .048).In older Black RTR, basiliximab induction followed by ESW produced comparable patient, graft, and rejection‐free survival compared to Non‐Black RTR over 3 years post‐transplant.Keywords
This publication has 21 references indexed in Scilit:
- OPTN/SRTR 2020 Annual Data Report: KidneyAmerican Journal of Transplantation, 2022
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without RaceNew England Journal of Medicine, 2021
- Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry AnalysisTransplantation, 2021
- Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task ForceAmerican Journal of Kidney Diseases, 2021
- Kidney Transplantation in Elderly Recipients: A Single-Center ExperienceTransplantation Proceedings, 2019
- Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipientsClinical Transplantation, 2017
- The risk of acute rejection and the influence of induction agents in lower‐risk African American kidney transplant recipients receiving modern immunosuppressionClinical Transplantation, 2014
- A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid TherapyAnnals of Surgery, 2008
- Racial Disparities in Renal Allograft Survival: A Public Health Issue?Journal of the American College of Surgeons, 2007
- Racial Differences in the Survival of Cadaveric Renal AllograftsNew England Journal of Medicine, 1992